Ligation of CD40 influences the function of human Ig-secreting B cell hybridomas both positively and negatively

Journal of Immunology

Volumn 156, Issue 9, 1996, Pages 3118-3132

  Bergman, Mary C ^a   Attrep, Jeanne F ^a   Grammer, Amrie C ^a   Lipsky, Peter E ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN;

ARTICLE; B LYMPHOCYTE; GENETIC RECOMBINATION; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL;

ADULT; ANIMALS; ANTIGENS, CD40; APOPTOSIS; B-LYMPHOCYTES; BASE SEQUENCE; BIOLOGICAL MARKERS; CD40 LIGAND; CELL AGGREGATION; HUMANS; HYBRIDOMAS; IMMUNOGLOBULINS; LIGANDS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MOLECULAR SEQUENCE DATA; PROTEIN BINDING;

EID: 0029931056     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (101)

1. Stamenkovic, I., E. A. Clark, and B. Seed. 1989. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 8:1403.
2. Smith, C., T. Davis, D. Anderson, L. Solam, M. Bechmann, T. Jerzey, S. Dower, D. Cosman, and R. Goodwin. 1990. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 248:1019.
3. Smith, C. A., T. Farrah, and R. G. Goodwin. 1994. The TNF receptor super-family of cellular and viral proteins: activation, eostimulation, and death. Cell 76:959.
4. Johnson, D., A. Lanahan, C. R. Buck, A. Sehgal, C. Morgan, E. Mercer, M. Bothwell, and M. Chao. 1986. Expression and structure of the human NGF receptor. Cell 47:545.
5. Ling, N. R., I. C. M. MacLennan, and D. Mason. 1987. B-cell and plasma cell antigens: new and previously defined clusters. In Leucocyte Typing III. A. J. Michael, ed. Oxford University Press, Oxford, p. 302.
6. Freudenthal, P. S., and R. M. Steinman. 1990. The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc. Natl. Acad. Sci. USA 87:7698.
7. Freudenthal, P. S., and R. M. Steinman. 1990. The distinct surface of human blood dendritic cells, as observed after an improved isolation method. Proc. Natl. Acad. Sci. USA 87:7698.
8. Schreiver, F., A. S. Freedman, G. Freeman, E. Messner, G. Lee, J. Dalcy, and L. M. Nadler. 1989. Isolated follicular dendritic cells display a unique antigenic phenotype. J. Exp. Med. 169:2043.
9. Saeland, S., V. Duvert, I. Moreau, and J. Banchereau. 1993. Human B cell precursors proliferate and express CD23 after CD40 ligation. J. Exp. Med. 178: 113.
10. + hematopoietic cells. Exp. Hematol. 20:24.
11. Galy. A. H. M., and H. Spits. 1992. CD40 is functionally expressed on human thymic epithelial cells. J. Immunol. 149:775.
12. Koho, H., S. Paulie, H. Ben-Aissa, I. Jonsdottir, Y. Hansson, M. L. Lundblad, and P. Perlman. 1984. Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. I. Determination of the selectivity of six antibodies by cell ELISA and immunofluorescence. Cancer Immunol. Immunother. 17:165.
13. Ledbetter, J. A., E. A. Clark, N. A. Norris, G. Shu, and I. Helstrom. 1987. Expression of a functional B-cell receptor CDW40 (Bp50) on carcinomas. In Leucocyte Typing. III. White Cell Differentiation Antigens. A. J. Michael, ed. Oxford University Press, Oxford, p. 432.
14. Koho, H., S. Paulie, H. Ben-Aissa, I. Jonsdottir, Y. Hansson, M. L. Lundblad, and P. Perlman. 1984. Monoclonal antibodies to antigens associated with transitional cell carcinoma of the human urinary bladder. I. Determination of the selectivity of six antibodies by cell ELISA and immunofluorescence. Cancer Immunol. Immunother. 17:165.
15. Dunlap, N. E., A. K. Berry, I. Gore, W. D. Decker, T. L. Snyder, G. M. Shaw, B. H. Hanh, and A. B. Tildem. 1989. Expression of activation antigens on HTLV-1 and THLV-II cell lines. In Leucocyte Typing IV. W. Knapp, ed. Oxford University Press, Oxford, p. 487.
16. Paulie, S., B. Ehlin-Henriksson, H. Mellstedt, H. Koho, H. Ben-Aissa, and P. Perlmann. 1985. A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Cancer Immunol. Immunother. 20:23.
17. Noelle, R. J., J. A. Ledbetter, and A. Aruffo. 1992. CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. Immunol. Today 13:431.
18. Spriggs, M. K., W. C. Fanslow, R. J. Armitage, and J. Belmont. 1993. The biology of human ligand for CD40. J. Clin. Immunol. 13:373.
19. Gauchet, J.-F., S. Henchoz, G. Mazzei, J.-P. Aubry, T. Brunner, H. Blasey, P. Life, D. Talabot, L. Flores-Remo, J. Thompson, K. Kishi, J. Butterfield, C. Dahinden, and J.-Y. Bonnefoy. 1993. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365:340.
20. Grammer, A. C., M. C. Bergman, Y. Miura, K. Fujita, L. S. Davis, and P. Lipsky. 1995. The CD40 ligand expressed by human B cells costimulates B cell responses. J. Immunol. 154:4996.
21. Banchereau, J., P. De Paoli, A. Valle, E. Garcia, and F. Rousset. 1991. Long-term human B cell lines dependent on interleukin-4 and antibody to CD40. Science 251:70.
22. Banchereau, J., and F. Rousset. 1991. Growing human B lymphocytes in the CD40 system. Nature 353:678.
23. Jabara, H. H., S. M. Fu, R. S. Geha, and D. Vercelli. 1990. CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells. J. Exp. Med. 172: 1861.
24. Noelle, R. J., J. A. Ledbetter, and A. Aruffo. 1992. CD40 and its ligand, an essential lisand-receptor pair for thymus-dependent B-cell activation. Immunol. Today 13:431.
25. Nishioka, Y., and P. E. Lipsky. 1994. The role of CD40-CD40 ligand interaction in human T cell-B cell collaboration. J. Immunol. 153:1027.
26. Tohma, S., S. Hirohata, and P. E. Lipsky. 1991. Role of CD18a/CD18-CD54 interaction in human T cell-dependent B cell activation. J. Immunol. 146:492.
27. Kawabe, T., T. Naka, K. Yoshida, T. Tanaka, Fujiwara, S. Suematsu, N. Yoshida, T. Kishimoto, and H. Kikutani. 1994. The immune responses in CD40-deficient mice: impaired immunoglobulin class switching and germinal center formation. Immunity 1:167.
28. Xu, J., T. M. Foy, J. D. Laman, E. A. Elliott, J. J. Dunn, T. J. Waldschmidt, J. Elsemore, R. Noelle, and R. A. Flavell. 1994. Mice deficient for the CD40 ligand. Immunity 1:423.
29. Renshaw, B. R., W. C. Fanslow III, R. J. Armitage, K. A. Campbell, D. Liggitt, B. Wright, B. L. Davidson, and C. R. Maliszewski. 1994. Humoral immune responses in CD40 ligand-deficient mice. J. Exp. Med. 180:1889.
30. Valle, A., C. E. Zuber, T. Defrance, O. Djossou, M. De Rie, and J. Banchereau. 1989. Activation of human B lymphocytes through CD40 and interleukin 4. Eur. J. Immunol. 19:1463.
31. Barrett, T. B., G. Shu, and E. A. Clark. 1991. CD40 signaling activates CD11a/ CD18 (LFA-1)-mediated adhesion in B cells. J. Immunol. 146:1722.
32. Kansas, G. S., and T. F. Tedder. 1991. Transmembrane signals generated through MHC class II, CD19, CD20, CD39, and CD40 antigens induce LFA-1-dependent and independent adhesion in human B cells through A tyrosine kinase-dependent pathway. J. Immunol. 147:4094.
33. Bjorck, P., B. Axelsson, and S. Paulie. 1991. Expression of CD40 and CD43 during activation of human B lymphocytes. Scand. J. Immunol. 33:211.
34. Kansas, G. S., G. S. Wood, and T. F. Tedder. 1991. Expression, distribution, and biochemistry of human CD39: role in activation-associated homotypic adhesion of lymphocytes. J. Immunol. 146:2235.
35. Spriggs, M. K., R. J. Armitage, L. Strockbine, K. N. Clifford, B. M. Macduff, T. A. Sato, C. R. Maliszewski, and W. C. Fanslow. 1992. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J. Exp. Med. 176:1543.
36. Hollenbaugh, D., L. S. Grosmaire, C. D. Kullas, N. J. Chalupny, S. Braesch-Anderson, R. J. Noelle, I. Stamenkovic, J. A. Ledbetter, and A. Aruffo. 1992. The human T cell antigen gp39, a member of the TNF gene family is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell costimulatory activity. EMBO J. 11:4313.
37. Clark, E. A., and J. A. Ledbetter. 1986. Activation of human B cells through two distinct cell surface differentiation antigens., Bp35 and Bp50. Proc. Natl. Acad. Sci. USA 83:4494.
38. Ledbetter, J. A., G. Shu, M. Gallagher, and E. A. Clark. 1987. Augmentation of normal and malignant B cell proliferation by monoclonal antibody to the B cell specific antigen Bp50 (CDw40). J. Immunol. 138:788.
39. Lane, P., T. Brocker, S. Hubele, E. Padovan, A. Lanzavecchia, and F. McConnell. 1993. Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell dependent activation. J. Exp. Med. 177:1209.
40. Armitage, R. J., B. M. Macduff, M. K. Spriggs, and W. C. Fanslow. 1993. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J. Immunol. 150:3671.
41. + T cell clones and IL-4 induce IgG4 and IgE switching in purified human B cells via different signaling pathways. J. Immunol. 147:8.
42. Zhang, K. E., E. A. Clark, and A. Saxon. 1991. CD40 stimulation provides an IFN-γ-dependent differentiation signal directly to human B cells for IgE production. J. Immunol. 146:1836.
43. Rousset, F., E. Garcia, and J. Banchereau. 1991. Cytokine-induced proliferation and immunoglobulin production of human B lymphocytes triggered through their CD40 antigen. J. Exp. Med. 173:705.
44. Shapira, S. K., D. Vecelli, H. H. Jabara, S. M. Fu, and R. S. Geha. 1992. Molecular analysis of the induction of immunoglobulin E synthesis in human B cells by interleukin 4 and engagement of CD40 antigen. J. Exp. Med. 175:289.
45. Defrance, T., B. Vanbervliet, F. Briere, I. Durand, F. Rousset, and J. Branchereau. 1992. Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J. Exp. Med. 175:671.
46. Cocks, B. G., R. de Waal Malefyt, J.-P. Galazzi, J. E. de Vries, and G. Aversa. 1993. IL-13 induces proliferation and differentiation of human B cells activated by the CD40 ligand. Int. Immunol. 5:657.
47. Splawski, J., S. M. Fu, and P. E. Lipsky. 1993. Immunoregulatory role of CD40 in human B cell differentiation. J. Immunol. 150:1276.
48. - B cell subsets activated through their antigen receptors or CD40 antigens. Eur. J. Immunol. 22: 2831.
49. Braesch-Andersen, S., S. Paulic, H. Koho, H. Nika, P. Aspenstrom, and P. Perlmann. 1989. Biochemical characteristics and partial amino acid sequence of the receptor-like human B cell and carcinoma antigen CDw40. J. Immunol. 142:562.
50. Schall, T., M. Lewis, K. Koller, A. Lee, G. Rice, G. Wong, G. Gatanaga, R. Lentz, H. Raab, W. Kohr, and D. Goeddel. 1990. Molecular cloning and expression of a receptor for human necrosis factor. Cell 61:361.
51. Yonehara, S., A. Ishii, and M. Yonehara. 1989. A cell-killing monoclonal antibody (anti-FAS) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169:1747.
52. Trauth, B. D., C. Klas, A. M. Peters, S. Matzuku, P. Moller, W. Falk, K. M. Debatin, and P. H. Krammer. 1989. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245:301.
53. Dhein, J., H. Walczak, C. Baumler, K.-M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(FAS/CD95). Nature 373:438.
54. Rudert, F., M. Roos, L. Forbes, and J. Watson. 1994. Apoptosis in L929 cells expressing a CD40/Fas chimetric receptor: dissociation of stimulatory from inhibitory death signalling functions. Biochem. Biophys. Res. Commun. 204:1102.
55. Itoh, N., and S. Nagata. 1993. A novel protein domain required for apoptosis: mutational analysis of human FAS antigen., J. Biol. Chem. 268:10932.
56. Tartaglia, L. A., T. M. Ayres, G. H. W. Wong, and D. V. Goeddel. 1993. A novel domain within the 55 kd TNF receptor signals cell death. Cell 74:845.
57. Rothe, M., V. Sarma, V. M. Dixit, and D. V. Goeddel. 1995. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269:1424.
58. Heath, A. W., R. Chang, N. Harada, L. Santos-Argumedo, J. Gordon, C. Hannum, D. Campbell, A. B. Shanafelt, E. A. Clark, R. Torres, and M. Howard., 1993. Antibodies to murine CD40 stimulate normal B lymphocytes but inhibit proliferation of B lymphoma cells. Cell Immunol. 152:468.
59. Fluckiger, A. C., J. F. Rossi, A. Bussel, P. Byron, J. Bancereau, and T. Defrance. 1992. Responsiveness of chronic lymphocytic leukemia B cells activated via surface Igs or CD40 to B-cell tropic factors. Blood 80:3173.
60. Funakoshi, S., D. L. Longo, M. Beckwith, D. K. Conley, G. Tsarfaty, I. Tsarfaty, R. J. Armitage, W. C. Fanslow, M. K. Spriggs, and W. J. Murphy. 1994. Inhibition of human B-cell lymphoma growth by CD40 stimulation. Blood 83:2787.
61. Hess, S., and H. Engelmann. 1996. A novel function of CD40: induction of cell death in transformed cells. J. Exp. Med. 183:159.
62. Kung, C. K., G. Goldstein, E. Reinherz, and S. F. Schlossman. 1979. Monoclonal antibodies defining distinctive human T cell surface antigens. Science 206:347.
63. Castle, B. E., K. Kishimoto, C. Steams, M. L. Brown, and M. R. Kehry. 1993. Regulation of expression of the ligand for CD40 on T helper lymphocytes. J. Immunol. 151:1777.
64. Boyum, A. 1968. Isolation of mononuclear sells and granulocytes from human blood: isolation of mononuclear cells by one centrifugation and sedimentation at 1 g. Scand. J. Clin. Lab. Invest. 21(Suppl. 97):77.
65. Theile, D. L., M. Kurosaka, and P. E. Lipsky. 1983. Phenotype of the accessory cell necessary for mitogen-stimulated T and B cell responses in human peripheral blood: delineation by its sensitivity to the lysosomotrophic agent, L-leucine methyl ester. J. Immunol. 131:2282.
66. Theile, D. L., and P. E. Lipsky. 1985. Regulation of cellular function by product of lysosomal enzyme activity: elimination of human natural killer cells by dipeptide methyl ester generated from L-leucine methyl ester by monocytes or polymorphonuclear leukocyte. Proc. Natl. Acad. Sci. USA 82:2468.
67. Galili, U., and M. Schlesinger. 1974. The formation of stable E rosettes after neuraminidase treatment of either human peripheral blood lymphocytes or of sheep red blood cells. J. Immunol. 112:1628.
68. Jelinek, D., and P. E. Lipsky. 1985. The role of T cell factors in activation, cell cycle progression, and differentiation of human B cells. J. Immunol. 134:1690.
69. Tohma, S., and P. E. Lipsky. 1991. Analysis of the mechanisms of T cell-dependent polyclonal activation of human B cells. J. Immunol. 146:2544.
70. Tohma, S., S. Hirohata, and P. E. Lipsky. 1991. The role of CD18a/CD18-CD54 interactions in human T cell-dependent B cell activation. J. Immunol. 146:2544.
71. Ostberg, L., and E. Pursch. 1983. Human X (mouse X human) hybridomas stably producing human antibodies. Hybridoma 2:361.
72. Mosmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55.
73. Jumper, M. D., Y. Nishioka, L. S. Davis, P. E. Lipsky, and K. Meek. 1995. Regulation of human B cell function by recombinant CD40 ligand and other TNF related ligands. J. Immunol. 155:2369.
74. Cascino, I., G. Fiucci, G. Papoff, and G. Ruperti. 1995. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. J. Immunol. 154:2706.
75. Takahashi, T., M. Tranaka, J. Inazawa, T. Abe, T. Suda, and S. Nagata. 1994. Human Fas ligand: gene structure, chromosomal location and species specificity. Int. Immunol. 6:1567.
76. Tang, H., T. Matthes, N. Carballido-Perrig, R. Zubler, and V. Kindler. 1993. Differential induction of T cell cytokine mRNA in Epstein-Barr virus-transformed B cell clones: constitutive and inducible expression of interleukin-4 mRNA. Eur. J. Immunol. 23:899.
77. Gorcza, W., J. Gong, and Z. Darzynkiewcz. 1993. Detection of DNA strand breaks individual apoptotic cells by the in situ terminal deoxynucleotidyl transferase and nick translation assays. Cancer Res. 53:1945.
78. Peitsch, M. C., and C. V. Jongeneel. 1992. A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors. Int. Immunol. 5:233.
79. Kroese, F. G., A. S. Wubbena, H. G. Seijen, and P. Nieuwenhuis. 1987. Germinal centers develop oligoclonally. Eur. J. Immunol. 17:1069.
80. Kosco, M. H. 1991. Germinal centers and the immune response. Res. Immunol. 142:219.
81. Yellin, M. J., K. Sippel, G. Inghirami, L. R. Covey, J. J. Lee, J. Sinning, E. A. Clark, L. Chess, and S. Lederman. 1994. CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule/ CD40-L: potential role in regulating helper effector function. J. Immunol. 152: 598.
82. van Kooten, C., C. Gaillard, J.-P. Galizzi, P. Hermann, F. Fossiez, J. Banchereau, and D. Blanchard. 1994. B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through release of soluble CD40. Eur. J. Immunol. 24:787.
83. Berberich, I., G. L. Shu, and E. A. Clark. 1994. Cross-linking CD40 on B cells rapidly activates nuclear factor-κB. J. Immunol. 153:4357.
84. Choi, M. S. K., R. D. Brines, M. J. Holman, and G. G. B. Klaus. 1994. Induction of NF-AT in normal B lymphocytes by anti-immunoglobulin or CD40 ligand in conjunction with IL-4. Immunity 1:179.
85. Sabelko, K., D. Blumenthal, M. Nahm, R. Ford, and J. Ambus, Jr. 1994. IL14 producing and responsive cells are found in germinal centers. FASEB J. 8:A999.
86. Kamesaki, H., J. A. Zweibel, J. C. Reed, and J. Cossman. 1994. Role of bcl-2 and FL-5 in the regulation of anti-IgM-induced growth arrest and apoptosis in immature B cell lines. J. Immunol. 152:3294.
87. Liu, Y.-J., D. E. Joshua, G. T. Williams, C. A. Smith, J. Gordon, and I. C. MacLennan. 1989. Mechanism of antigen-driven selection in germinal centres. Nature 342:929.
88. Liu, Y.-J., D. Y. Mason, G. D. Johnson, S. Abbot, C. D. Gregory, D. L. Hardie, J. Gordon, and I. C. M. MacLennan. 1991. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur. J. Immunol. 21:1905.
89. Holder, M. J., H. Wang, A. E. Milner, M. Casamayor, R. Armitage, M. K. Spriggs, W. C. Fanslow, I. C. M. MacLennan, C. D. Gregory, and J. Gordon. 1993. Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bcl-2 induction. Eur. J. Immunol. 23:2368.
90. Hsu, H., J. Xiong, and D. V. Goeddel. 1995. The TNF receptor 1 Associated protein TRADD signals cell death and NF-κB activation. Cell 81:495.
91. Chinnaiyan, A. M., K. O'Rourke, M. Tewari, and V. M. Dixit. 1995. FADD, a novel death domain-containing protein, interacts with the death domain of FAS and initiates apoptosis. Cell 81:505.
92. Itoh, N., S. Yonehara, A. Ishii, M. Yonehara, S.-I. Mizushima, M. Sameshima, A. Hase, Y. Seto, and S. Nagata. 1991. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233.
93. Oehm, A., I. Behrmann, W. Falk, M. Tawlita, G. Maier, C. Klas, M. Li-Weber, S. Richards, J. Dhein, B. C. Trauth, H. Ponsting, and P. H. Krammer. 1992. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the TNF/NGF receptor superfamily sequence identity with the Fas antigen. J. Biol. Chem. 267:10709.
94. Suda, T., T. Okazaki, Y. Naito, T. Yokota, N. Aral, S. Ozaki, K. Nakao, and S. Nagata. 1995. Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 154:3806.
95. Dhein, J., H. Walczak, C. Baumler, K.-M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1/(FAS/CD95). Nature 373:438.
96. Cifone, M. G., R. De Maria, P. Roncaioli, M. R. Rippo, M. Azuma, L. Lanier, A. Santoni, and R. Testi. 1994. Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic splungomyelinase. J. Exp. Med. 180:1547.
97. Jarvis, W. D., R. N. Kolesnick, F. A. Fornari, R. S. Traylor, D. A. Gewirtz, and S. Grant. 1994. Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc. Natl. Acad. Sci. USA 91:73.
98. Kolesnick, R., and Golde, D. W. 1994. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77:325.
99. L rescues WEHI 231 B lymphocytes from oxidant-mediated death following diverse apoptotic stimuli. J. Immunol. 155:66.
100. Benhamou, L. E., P. A. Cazenave, and P. Sarthou. 1990. Anti-immunoglobulins induce cell death by apoptosis in WEHI-231 B lymphoma cells. Eur. J. Immunol. 20:1405.
101. Hasbold, J., and G. G. Klaus. 1990. Anti-immunoglobulin antibodies induce apoptosis in immature B cell lymphomas. Eur. J. Immunol. 20:1685.